Rat Amyloid β Protein 42 ELISA kit
Specifications
| Product Cat#: | EK-07-0418 |
| Product name: | Rat Amyloid β Protein 42 ELISA kit |
| Target Name: | Aβ42 |
| Species Reactivity: | Rat |
| Product Size: | 48/96 Tests |
| Sensitivity: | 4.9 pg/ml |
| Assay range: | 50-1000 pg/ml |
| Assay Time: | 90 minutes |
| Platform: | Colorimetric Microplate Reader |
| Conjugate: | HRP |
| ELISA Type: | Sandwich ELISA |
| Detection Method: | Colorimetric |
| Storage temperature: | Store at 2-8°C |
| Stability: | Stable within the expiration date under suggested storage conditions |
| Shipping condition: | Wet ice |
| Kit Contents: | Microtiter plate (1x), Enzyme conjugate (1 vial), Standard samples (6 vials), |
| Substrates (A & B, 2 vials), Stop solution (1 vial), Wash Solution (100x, 1 vial), | |
| Balance solution (1 vial), Instruction (1 copy) | |
| Other Names of Target: | Beta amyloid(1-42); Beta amyloid 1-42; Beta-amyloid 1-42; Amyloid 1-42; Beta-amyloid 42; A4; AAA; ABETA; ABPP; AD1; Alzheimers disease amyloid protein; Amyloid B; Amyloid beta A4 protein precursor; Amyloid beta; Amyloid of aging and alzheimer disease; APP; APPI; B amyloid; Beta APP; Cerebral vascular amyloid peptide; CTFgamma; CVAP; PN II; PN2; PreA4; Protease nexin II; A beta; A4_HUMAN |
Target information
The cerebral and vascular plaques associated with Alzheimer’s disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer’s disease. beta Amyloid antibodies and peptides have been developed as tools for elucidating the biology of Alzheimer’s disease.
Provider
Erpantech Laboratory
